Cargando…

Somatostatin analogues labeled with copper radioisotopes: current status

Peptide receptor radionuclide therapy (PRRT) is a promising way to treat patients with inoperable tumors or metastatic neuroendocrine tumors. This therapeutic strategy is using radiolabeled peptides, which are capable of selective biding to receptors overexpressed in the cancer cells. One of the gro...

Descripción completa

Detalles Bibliográficos
Autores principales: Marciniak, Aleksandra, Brasuń, Justyna
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Netherlands 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5533839/
https://www.ncbi.nlm.nih.gov/pubmed/28804185
http://dx.doi.org/10.1007/s10967-017-5323-x